Regis Healthcare Ltd
ASX:REG

Watchlist Manager
Regis Healthcare Ltd Logo
Regis Healthcare Ltd
ASX:REG
Watchlist
Price: 7.6 AUD 2.98% Market Closed
Market Cap: 2.3B AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

REG Price Targets Summary
Regis Healthcare Ltd

Wall Street analysts forecast REG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REG is 8.21 AUD with a low forecast of 7.32 AUD and a high forecast of 10.76 AUD.

REG Lowest Forecast
Wall Street Target
7.32 AUD
4% Downside
REG Average Forecast
Wall Street Target
8.21 AUD
8% Upside
REG Highest Forecast
Wall Street Target
10.76 AUD
42% Upside
Lowest
Price Target
7.32 AUD
4% Downside
Average
Price Target
8.21 AUD
8% Upside
Highest
Price Target
10.76 AUD
42% Upside
Regis Healthcare Ltd Competitors:
Price Targets
RYM
Ryman Healthcare Ltd
43% Upside
P
PHG
Patrangsit Healthcare Group PCL
55% Upside
4002
Mouwasat Medical Services Company SJSC
2% Downside
RDOR3
Rede D'Or Sao Luiz SA
14% Upside
RYM
Ryman Healthcare Ltd
43% Upside
P
PHG
Patrangsit Healthcare Group PCL
55% Upside
4002
Mouwasat Medical Services Company SJSC
2% Downside
RDOR3
Rede D'Or Sao Luiz SA
14% Upside
PSQ
Pacific Smiles Group Ltd
10% Upside
HCG
Healthcare Global Enterprises Ltd
12% Upside
A
TRP
Aesthetic Connect PCL
4% Upside
H
301267
Huaxia Eye Hospital Group Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Regis Healthcare Ltd

For the last 8 years the compound annual growth rate for Regis Healthcare Ltd's revenue is 11%. The projected CAGR for the next 4 years is 8%.

11%
Past Growth
8%
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Regis Healthcare Ltd

For the last 8 years the compound annual growth rate for Regis Healthcare Ltd's operating income is -8%. The projected CAGR for the next 4 years is 29%.

-8%
Past Growth
29%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Regis Healthcare Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
REG intrinsic value, competitors valuation, and company profile.
DCF Valuation
REG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
REG stock valuation using valuation multiples.
Wall Street Estimates
REG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
REG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REG's stock price target?
Price Target
8.21 AUD

According to Wall Street analysts, the average 1-year price target for REG is 8.21 AUD with a low forecast of 7.32 AUD and a high forecast of 10.76 AUD.

What is Regis Healthcare Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Regis Healthcare Ltd's revenue is 11%. The projected CAGR for the next 4 years is 8%.

What is Regis Healthcare Ltd's Operating Income forecast?
Projected CAGR
29%

For the last 8 years the compound annual growth rate for Regis Healthcare Ltd's operating income is -8%. The projected CAGR for the next 4 years is 29%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.